Results 221 to 230 of about 20,702 (286)

LG 30435 is a new bronchodilator agent with multiple sites of action

, 1986
Alessandro Subissi, Marco Criscuoli, Anna Rita Renzetti   +2 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Recent progress in the treatment of cancer in children

Ca-A Cancer Journal for Clinicians, 2021
Theodore W Laetsch
exaly  

A comparative study of two parasympatholytic bronchodilator agents: ipratropium bromide and diphemanil methylsulfate.

, 1981
L. Diamond, Michael A. O’Donnell
openalex   +1 more source

Biotransformation of sympathomimetic agents and bronchodilators

1981
D. E. Hathway, L. G. Dring, P. Millburn
openaire   +1 more source

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

THE COMPARATIVE EFFECT OF BRONCHODILATOR AGENTS ADMINISTERED BY INHALATION

The American Journal of the Medical Sciences, 1958
LITTLE, R. C., POETTER, H. W.
openaire   +3 more sources

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

[Bronchodilator agents and their combinations].

Casopis lekaru ceskych, 1975
J, Růzicka, V, Vondra
openaire   +1 more source